San Francisco - Dermatopathologists from two U.S. universities and clinicians at a California renal transplant hospital have brought a new skin disease to the attention of the Centers for Disease Control and Prevention (CDC).
Deuruxolitinib Shows Efficacy in Hair Regrowth, Patient Satisfaction, and Psychosocial Wellbeing in Severe Alopecia Areata
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Melinda Gooderham, MSc, MD, FRCPC: Insights Into Lebrikizumab’s Sustained 3-Year Efficacy
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Post Hoc Analysis of Vilobelimab in Hidradenitis Suppurativa Suggests Clinically Meaningful Benefits
Upadacitinib Demonstrates Efficacy in Patients With AD and Head and Neck Involvement